IQ-AI Limited Update on Phase I Clinical Trial (3307L)
September 10 2021 - 1:00AM
UK Regulatory
TIDMIQAI
RNS Number : 3307L
IQ-AI Limited
10 September 2021
September 10, 2021
IQ-AI Limited
("IQ-AI" or the "Company")
IQ-AI update on Phase I clinical trial and software sales
IQ-AI Limited (LSE: IQAI, OTCQB: IQAIF) announces that the
Gallium Maltolate phase I clinical trial will now commence towards
the end of Q4 2021. This rescheduling is the consequence of a
change in the trial agent's encapsulation supplier.
While the selection and qualification process will result in a
delay, securing and establishing a robust supply chain now will
benefit subsequent trial phases and support high-volume production
capacity. Overall, the trial continues to advance at a remarkable
pace and has obtained all regulatory and institutional milestones
as scheduled.
Elsewhere, IQAI continues to experience increased interest in
its software platforms and further installations are anticipated to
be contracted during Q4, when the Company will also be deploying
its software at two more US National Cancer Institute-designated
cancer centres on a trial basis.
The Directors of the Company accept responsibility for the
contents of this announcement.
IQ-AI Limited
Trevor Brown/Vinod Kaushal/Brett Skelly/Michael
Schmainda 0207 469 0930
Peterhouse Capital Limited
Lucy Williams/Heena Karani 0207 220 9797
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RESBLGDCDXGDGBC
(END) Dow Jones Newswires
September 10, 2021 02:00 ET (06:00 GMT)
Iq-ai (LSE:IQAI)
Historical Stock Chart
From Apr 2024 to May 2024
Iq-ai (LSE:IQAI)
Historical Stock Chart
From May 2023 to May 2024